Arrowhead Pharmaceuticals Inc Earnings
The next earnings date for Arrowhead Pharmaceuticals Inc is August 6, 2026.
They are scheduled to announce earnings after the market closes that day.
Analyst Estimates of Arrowhead Pharmaceuticals Inc Earnings
| 08/06/2026 | $-1.16 |
What is an Earnings Date
An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.
Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.
Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.
Arrowhead Pharmaceuticals Inc Earnings: Historical
| 05/07/2026 | After Market | $-0.93 | 16.22% |
| 02/05/2026 | After Market | $0.22 | 159.46% |
| 11/25/2025 | --- | $-0.11 | 64.50% |
| 08/07/2025 | After Market | $-1.26 | -34.04% |
| 05/12/2025 | After Market | $2.75 | 697.83% |
| 02/10/2025 | After Market | $-1.39 | -93.06% |
| 11/27/2024 | Before Market | $-1.37 | -48.59% |
| 08/08/2024 | After Market | $-1.38 | -133.90% |
| 05/09/2024 | After Market | $-1.02 | -410.00% |
| 02/06/2024 | After Market | $-1.24 | -49.40% |
More About Arrowhead Pharmaceuticals Inc
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.
“Arrowhead Pharmaceuticals Inc Earnings” Can Refer to the Arrowhead Pharmaceuticals Inc Earnings Date
Some people say “Arrowhead Pharmaceuticals Inc earnings” as a shortform way to refer to the earnings date.
For example, someone might say, “I plan to hold my Arrowhead Pharmaceuticals Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.
Owning Arrowhead Pharmaceuticals Inc Stock on the Earnings Date
If you own Arrowhead Pharmaceuticals Inc stock (ARWR) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Arrowhead Pharmaceuticals Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.
There is often a big audience of investors involved with trading Arrowhead Pharmaceuticals Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.
These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.
Learning More Arrowhead Pharmaceuticals Inc Earnings
You can contact us any time if you would like to ask questions about Arrowhead Pharmaceuticals Inc earnings or anything else related to the stock market.